• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconRegeneron Pharmaceuticals

Regeneron Pharmaceuticals

U.S. President Donald Trump walks out of the Oval Office for a signing ceremony for S. 146, the Take It Down Act, in the Rose Garden of the White House in Washington, DC, on May 19, 2025.(Photo: Samuel Corum/Bloomberg/Getty Images)
NewslettersTrump signs AI deepfake bill into law
By Andrew NuscaMay 20, 2025
Leonard Schleifer
HealthRegeneron is buying 23andMe out of bankruptcy for $256 million
By Michelle Chapman and The Associated PressMay 19, 2025
As part of its quest to “discover the science of humanity,” the Truveta Genome Project will gather the de-identified genetic data of tens of millions of consented volunteers, health data startup Truveta announced Jan. 13, 2025.
HealthPharma giant Regeneron is spending $119.5M on the world’s largest, most diverse genetic database using DNA from patient volunteers
By Lindsey LeakeJanuary 16, 2025
Jensen Huang, Mark Zuckerberg, and Marc Benioff.
Leadership22 CEOs who founded their Fortune 500 companies
By Emma BurleighJune 4, 2024
Albert Bourla, chairman and chief executive officer of Pfizer Inc., speaks during South By Southwest.
HealthThe most innovative and inventive drug companies of 2022 set the foundation for success before the pandemic
By Sy Mukherjee and IDEA PharmaApril 20, 2022
Regeneron antibody COVID treatment
HealthBiden administration moves to prevent shortage of COVID-19 antibody treatments
By Riley Griffin, Emma Court and BloombergSeptember 15, 2021
Meet the most innovative and inventive pharmaceutical companies of 2021
HealthMeet the most innovative and inventive pharmaceutical companies of 2021
By Sy Mukherjee and IDEA PharmaApril 16, 2021
Eli Lilly COVID drug cocktail
HealthCOVID treatments like the experimental antibody therapeutic Trump received are making progress
By Sy MukherjeeOctober 7, 2020
Trump is being treated with a COVID drug that wasn’t one of the questionable therapies he’s previously touted
HealthTrump is being treated with a COVID drug that wasn’t one of the questionable therapies he’s previously touted
By Sy MukherjeeOctober 2, 2020
Regeneron George Yancopoulos graduation speech All Lives Matter
HealthDrug giant Regeneron responds to backlash over cofounder’s ‘All Lives Matter’ graduation speech
By Sy MukherjeeJuly 2, 2020
Will COVID-19 change how Big Pharma does clinical trials?
MagazineWill COVID-19 change how Big Pharma does clinical trials?
By Erika FryMay 15, 2020
Paul Hudson, chief executive officer of Sanofi, gestures as he speaks during a panel session on the sidelines of the China International Import Expo (CIIE) in Shanghai, China, on Tuesday, Nov. 5, 2019. The CIIE -- now in its second year -- is designed to showcase the countrys desire to shift its economy toward consumption by buying more foreign goods. Photographer: Qilai Shen/Bloomberg via Getty Images
NewslettersBig pharma’s big chance
By Katherine Dunn and Alan MurrayApril 3, 2020
Ebola drugs cure Congo
NewslettersA Promising Pair of Ebola Drugs Raises Hopes in Africa: Brainstorm Health
By Sy MukherjeeAugust 12, 2019
Allergy Test, Child
HealthSanofi, Regeneron Win FDA Approval for Eczema Drug With Multi-Billion Dollar Potential
By Sy MukherjeeMarch 28, 2017
These 3 Ugly Patent Battles Could Rock Biopharma’s 2017
HealthThese 3 Ugly Patent Battles Could Rock Biopharma’s 2017
By Sy MukherjeeJanuary 7, 2017
1
  • 1
  • 2
2
Most Popular
Real Estate
Gen Z fled San Francisco for Texas and Florida. Now they’re turning ‘welcomer cities’ into the next big tech townsplaceholder alt text
By Sydney LakeJune 13, 2026
AI
Anthropic disables Fable and Mythos AI models after U.S. government bars it from giving foreigners accessplaceholder alt text
By Jeremy KahnJune 13, 2026
Startups & Venture
Melinda French Gates' advice to new IPO millionaires: 'Give half your money away'placeholder alt text
By Emma HinchliffeJune 13, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.